Enteromorpha Polysaccharides Alleviate High‐Fat Diet‐Induced Glucolipid Metabolism Disorders via the K18‐Mediated IRS‐1/PI3K/AKT/GSK3β Pathway
Journal of Food Science · 2025
DOI: 10.1111/1750-3841.70713 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food Science, 2025. Verfasst von Bingbing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Inspection and Quarantine, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Diet, High-Fat, Polysaccharides, Non-alcoholic Fatty Liver Disease, Ulva. Die Arbeit nennt 71 Literaturangaben. Gefördert von: Project of Fujian Medical University, Young and Middle-aged Backbone Foundation of the Fujian Provincial Health Commission.
Abstract (Originalsprache)
Previous studies have shown that enteromorpha polysaccharide (EP) can improve glucolipid metabolism disorders, but the mechanism remains unclear. In this study, both a high‐fat diet‐induced NAFLD animal model and a cellular model exposed to free fatty acids (FFAs) were used to explore the intervention effects of EP and its mechanism in glucolipid metabolism disorders. The results revealed that a high‐fat diet could induce hepatic steatosis and glucolipid metabolism disorders, along with decreased expression of IRS‐1 and increased levels of K18, p‐K18, p‐PI3K, and p‐AKT ( p < 0.05). In addition, the serum K18 levels in NAFLD mice were increased. Intervention with EP significantly counteracted the high‐fat diet‐induced disturbances in glucose and lipid metabolism associated with NAFLD, downregulated the protein expression of hepatic K18, and decreased the levels of p‐AKT, p‐PI3K/PI3K, and p‐AKT/AKT ( p < 0.05). Knocking down K18 can directly regulate the PI3K/AKT signaling pathway. Additionally, the increases in p‐PI3K/PI3K and p‐AKT/AKT induced by FFAs were partially reversed after K18 was knocked down. Consequently, our findings highlight the pivotal regulatory role of K18 in modulating the high‐fat diet‐induced disturbances in glucolipid metabolism associated with NAFLD. Moreover, EP partially ameliorated glucolipid metabolism disorders via the K18‐mediated IRS‐1/PI3K/AKT/GSK3β pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Inspection and Quarantine, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.
- Department of Hepatology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.
- Fujian Province Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.
ORCID-Profile: Wenxiang Wang
Förderung
- Project of Fujian Medical University
- Young and Middle-aged Backbone Foundation of the Fujian Provincial Health Commission
Zitieren
APA
Wang, B., Wu, S., Huang, Z., Zhang, W., Sun, H., Zhu, L., Huang, Y., Zhao, A., & Wang, W. (2025). Enteromorpha Polysaccharides Alleviate High‐Fat Diet‐Induced Glucolipid Metabolism Disorders via the K18‐Mediated IRS‐1/PI3K/AKT/GSK3β Pathway. Journal of Food Science. https://doi.org/10.1111/1750-3841.70713
Vancouver
Wang B, Wu S, Huang Z, Zhang W, Sun H, Zhu L, et al. Enteromorpha Polysaccharides Alleviate High‐Fat Diet‐Induced Glucolipid Metabolism Disorders via the K18‐Mediated IRS‐1/PI3K/AKT/GSK3β Pathway. Journal of Food Science. 2025. doi:10.1111/1750-3841.70713
BibTeX
@article{Wang2025,
author = {Wang, Bingbing and Wu, Siyi and Huang, Zuxiong and Zhang, Wenhui and Sun, Han and Zhu, Lingling and Huang, Yanxin and Zhao, Aili and Wang, Wenxiang},
title = {Enteromorpha Polysaccharides Alleviate High‐Fat Diet‐Induced Glucolipid Metabolism Disorders via the K18‐Mediated IRS‐1/PI3K/AKT/GSK3β Pathway},
journal = {Journal of Food Science},
year = {2025},
doi = {10.1111/1750-3841.70713}
}
EUVIMED